Logo image of PCT

PURECYCLE TECHNOLOGIES INC (PCT) Stock Fundamental Analysis

NASDAQ:PCT - Nasdaq - US74623V1035 - Common Stock - Currency: USD

8.76  +0.29 (+3.36%)

After market: 8.8673 +0.11 (+1.22%)

Fundamental Rating

2

Taking everything into account, PCT scores 2 out of 10 in our fundamental rating. PCT was compared to 85 industry peers in the Chemicals industry. PCT has a bad profitability rating. Also its financial health evaluation is rather negative. PCT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year PCT has reported negative net income.
PCT had a negative operating cash flow in the past year.
PCT had negative earnings in each of the past 5 years.
PCT had a negative operating cash flow in each of the past 5 years.
PCT Yearly Net Income VS EBIT VS OCF VS FCFPCT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -100M -200M -300M

1.2 Ratios

PCT has a worse Return On Assets (-9.79%) than 81.93% of its industry peers.
PCT's Return On Equity of -24.20% is on the low side compared to the rest of the industry. PCT is outperformed by 83.13% of its industry peers.
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROIC N/A
ROA(3y)-10.43%
ROA(5y)-6.53%
ROE(3y)-20.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PCT Yearly ROA, ROE, ROICPCT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -5 -10 -15 -20

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PCT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PCT Yearly Profit, Operating, Gross MarginsPCT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023

More info and screens

3

2. Health

2.1 Basic Checks

The number of shares outstanding for PCT has been increased compared to 1 year ago.
The debt/assets ratio for PCT is higher compared to a year ago.
PCT Yearly Shares OutstandingPCT Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M
PCT Yearly Total Debt VS Total AssetsPCT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

PCT has an Altman-Z score of 0.72. This is a bad value and indicates that PCT is not financially healthy and even has some risk of bankruptcy.
PCT's Altman-Z score of 0.72 is on the low side compared to the rest of the industry. PCT is outperformed by 81.93% of its industry peers.
A Debt/Equity ratio of 1.21 is on the high side and indicates that PCT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.21, PCT is doing worse than 73.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACCN/A
WACCN/A
PCT Yearly LT Debt VS Equity VS FCFPCT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M -200M 400M

2.3 Liquidity

PCT has a Current Ratio of 2.92. This indicates that PCT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.92, PCT belongs to the best of the industry, outperforming 81.93% of the companies in the same industry.
PCT has a Quick Ratio of 2.92. This indicates that PCT is financially healthy and has no problem in meeting its short term obligations.
PCT has a Quick ratio of 2.92. This is amongst the best in the industry. PCT outperforms 90.36% of its industry peers.
Industry RankSector Rank
Current Ratio 2.92
Quick Ratio 2.92
PCT Yearly Current Assets VS Current LiabilitesPCT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

PCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -157.92%.
EPS 1Y (TTM)-157.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1900%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

PCT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.60% yearly.
PCT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 490.25% yearly.
EPS Next Y-156.04%
EPS Next 2Y-6.74%
EPS Next 3Y10.53%
EPS Next 5Y15.6%
Revenue Next Year2625%
Revenue Next 2Y2189.73%
Revenue Next 3Y905.64%
Revenue Next 5Y490.25%

3.3 Evolution

PCT Yearly Revenue VS EstimatesPCT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 500M 1B 1.5B
PCT Yearly EPS VS EstimatesPCT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PCT. In the last year negative earnings were reported.
Also next year PCT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PCT Price Earnings VS Forward Price EarningsPCT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCT Per share dataPCT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.74%
EPS Next 3Y10.53%

More info and screens

0

5. Dividend

5.1 Amount

PCT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PURECYCLE TECHNOLOGIES INC

NASDAQ:PCT (2/11/2025, 8:00:00 PM)

After market: 8.8673 +0.11 (+1.22%)

8.76

+0.29 (+3.36%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-15 2024-11-15/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners81.37%
Inst Owner Change-62.55%
Ins Owners3.5%
Ins Owner Change0.1%
Market Cap1.52B
Analysts77.78
Price Target13.86 (58.22%)
Short Float %23.58%
Short Ratio18.65
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)77.2%
Min EPS beat(2)35.6%
Max EPS beat(2)118.8%
EPS beat(4)2
Avg EPS beat(4)-11.18%
Min EPS beat(4)-173.23%
Max EPS beat(4)118.8%
EPS beat(8)4
Avg EPS beat(8)-9.63%
EPS beat(12)5
Avg EPS beat(12)-60.09%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)35.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-32.39%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-75.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.62
P/tB 3.62
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)-0.71
Fwd EYN/A
FCF(TTM)-1.43
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS0
BVpS2.42
TBVpS2.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.79%
ROE -24.2%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-10.43%
ROA(5y)-6.53%
ROE(3y)-20.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 1.21
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 965.79%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.92
Quick Ratio 2.92
Altman-Z 0.72
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)4982.36%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-157.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1900%
EPS Next Y-156.04%
EPS Next 2Y-6.74%
EPS Next 3Y10.53%
EPS Next 5Y15.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year2625%
Revenue Next 2Y2189.73%
Revenue Next 3Y905.64%
Revenue Next 5Y490.25%
EBIT growth 1Y-40.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year72.88%
EBIT Next 3Y36.95%
EBIT Next 5Y57.01%
FCF growth 1Y29.45%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-44.94%
OCF growth 3YN/A
OCF growth 5YN/A